Chargari C, et al. Brachytherapy: an overview for clinicians. CA Cancer J Clin. 2019;69(5):386–401. https://doi.org/10.3322/caac.21578.
Holm HH. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol. 1997;13(6):431–7. https://doi.org/10.1002/(sici)1098-2388(199711/12)13:6%3c431::aid-ssu7%3e3.0.co;2-b.
Article CAS PubMed Google Scholar
Petereit DG, et al. Brachytherapy: where has it gone? J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(9):980–2. https://doi.org/10.1200/JCO.2014.59.8128.
Aronowitz JN. A Century of Brachytherapy (From the Prostate’s Perspective). Springer, 2023. Accessed 16 Dec 2023. https://connect.springerpub.com/content/book/978-1-6170-5261-3/chapter/ch01
Hilaris BS. Brachytherapy in cancer of the prostate: an historical perspective. Semin Surg Oncol. 1997;13(6):399–405. https://doi.org/10.1002/(sici)1098-2388(199711/12)13:6%3c399::aid-ssu3%3e3.0.co;2-5.
Article CAS PubMed Google Scholar
Zaorsky NG, et al. Evolution of brachytherapy for prostate cancer. Nat Rev Urol. 2017;14(7):415–39. https://doi.org/10.1038/nrurol.2017.76.
Article PubMed PubMed Central Google Scholar
Chino J, et al. The ASTRO clinical practice guidelines in cervical cancer: optimizing radiation therapy for improved outcomes. Gynecol Oncol. 2020;159(3):607–10. https://doi.org/10.1016/j.ygyno.2020.09.015.
Chin J, et al. Brachytherapy for patients with prostate cancer: American society of clinical oncology/cancer care Ontario joint guideline update. J Clin Oncol. 2017;35(15):1737–43. https://doi.org/10.1200/JCO.2016.72.0466.
Orio PF, Nguyen PL, Buzurovic I, Cail DW, Chen Y-W. The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness. Brachytherapy. 2016;15(6):701–6. https://doi.org/10.1016/j.brachy.2016.05.001.
Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111–9. https://doi.org/10.1016/j.ijrobp.2013.05.033.
Martin JM, et al. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014;120(14):2114–21. https://doi.org/10.1002/cncr.28697.
Nabavizadeh N, et al. Results of the 2013–2015 association of residents in radiation oncology survey of chief residents in the United States. Int J Radiat Oncol Biol Phys. 2016;94(2):228–34. https://doi.org/10.1016/j.ijrobp.2015.10.014.
Orio PF, Nguyen PL, Buzurovic I, Cail DW, Chen Y-W. Prostate brachytherapy case volumes by academic and nonacademic practices: implications for future residency training. Int J Radiat Oncol Biol Phys. 2016;96(3):624–8. https://doi.org/10.1016/j.ijrobp.2016.07.013.
Bates JE, Thaker NG, Parekh A, Royce TJ. Geographic access to brachytherapy services in the United States. Brachytherapy. 2022;21(1):29–32. https://doi.org/10.1016/j.brachy.2021.05.004.
Marcrom SR, et al. Brachytherapy training survey of radiation oncology residents. Int J Radiat Oncol Biol Phys. 2019;103(3):557–60. https://doi.org/10.1016/j.ijrobp.2018.10.023.
Cihoric N, et al. Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database. Radiat Oncol. 2016;11(1):48. https://doi.org/10.1186/s13014-016-0624-8.
Article PubMed PubMed Central Google Scholar
Odei BCL, Boothe D, Lloyd S, Gaffney DK. A comprehensive analysis of brachytherapy clinical trials over the past 15 years. Brachytherapy. 2016;15(6):679–86. https://doi.org/10.1016/j.brachy.2016.06.014.
Cunha JAM, et al. Brachytherapy future directions. Semin Radiat Oncol. 2020;30(1):94–106. https://doi.org/10.1016/j.semradonc.2019.09.001.
Corkum MT, et al. Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada. Radiother Oncol. 2020;152:42–8. https://doi.org/10.1016/j.radonc.2020.07.036.
Article CAS PubMed Google Scholar
Ghazbani A, et al. Knowledge domain and emerging trends in brachytherapy: a scientometric analysis. Precis Radiat Oncol. 2022;6(3):243–56. https://doi.org/10.1002/pro6.1171.
Kahn JM, Campbell SR, Albert AA, Knoll MA, Shah C. #ThisIsBrachytherapy: increasing awareness of brachytherapy. Brachytherapy. 2021;20(1):232–6. https://doi.org/10.1016/j.brachy.2020.07.003.
Taunk NK, Shah NK, Hubley E, Anamalayil S, Trotter JW, Li T. Virtual reality-based simulation improves gynecologic brachytherapy proficiency, engagement, and trainee self-confidence. Brachytherapy. 2021;20(4):695–700. https://doi.org/10.1016/j.brachy.2021.03.003.
Williams VM, Mansoori B, Young L, Mayr NA, Halasz LM, Dyer BA. Simulation-based learning for enhanced gynecologic brachytherapy training among radiation oncology residents. Brachytherapy. 2021;20(1):128–35. https://doi.org/10.1016/j.brachy.2020.08.022.
Williams VM, et al. The case for brachytherapy: why it deserves a renaissance. Adv Radiat Oncol. 2021;6(2):100605. https://doi.org/10.1016/j.adro.2020.10.018.
Colson-Fearon D, Han K, Roumeliotis MB, Viswanathan AN. Updated Trends in Brachytherapy Utilization and Disparities in the United States from 2004 to 2020. Int J Radiat Oncol Biol Phys. 2023. https://doi.org/10.1016/j.ijrobp.2023.11.036.
Article PubMed PubMed Central Google Scholar
Han K, Colson-Fearon D, Liu ZA, Viswanathan AN. Updated trends in the utilization of brachytherapy in cervical cancer in the united states: a surveillance, epidemiology, and end-results study. Int J Radiat Oncol Biol Phys. 2023. https://doi.org/10.1016/j.ijrobp.2023.11.007.
Chargari C, et al. Radiotherapy of cervical cancer. Cancer Radiother J Soc Francaise Radiother Oncol. 2022;26(1–2):298–308. https://doi.org/10.1016/j.canrad.2021.11.009.
Viswanathan AN, Thomadsen B, American Brachytherapy Society Cervical Cancer Recommendations Committee, and American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012;11(1):33–46. https://doi.org/10.1016/j.brachy.2011.07.003.
Harkenrider MM, et al. Radiation therapy for endometrial cancer: an American society for radiation oncology clinical practice guideline. Pract Radiat Oncol. 2023;13(1):41–65. https://doi.org/10.1016/j.prro.2022.09.002.
Kamrava M, et al. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy. 2017;16(6):1129–43. https://doi.org/10.1016/j.brachy.2017.07.012.
Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73. https://doi.org/10.1038/nature12113.
RAINBO Research Consortium. Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 2022;33(1):109–117. https://doi.org/10.1136/ijgc-2022-004039.
Horeweg N, et al. Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2023;41(27):4369–80. https://doi.org/10.1200/JCO.23.00062.
Shah C, et al. The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation. Brachytherapy. 2018;17(1):154–70. https://doi.org/10.1016/j.brachy.2017.09.004.
Hepel JT, et al. American Brachytherapy Society consensus report for accelerated partial breast irradiation using interstitial multicatheter brachytherapy. Brachytherapy. 2017;16(5):919–28. https://doi.org/10.1016/j.brachy.2017.05.012.
Cozzi S, et al. The role of interstitial brachytherapy for breast cancer treatment: an overview of indications, applications, and technical notes. Cancers. 2022;14(10):2564. https://doi.org/10.3390/cancers14102564.
Article PubMed PubMed Central Google Scholar
Major T, et al. Recommendations from GEC ESTRO Breast Cancer Working Group (II): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving open cavity surgery. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2016;118(1):199–204. https://doi.org/10.1016/j.radonc.2015.12.006.
Schäfer R, et al. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018;19(6):834–44. https://doi.org/10.1016/S1470-2045(18)30195-5.
Hannoun-Levi J-M, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2
Comments (0)